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Imidazolium-tagged glycan probes for
non-covalent labeling of live cells†
David Benito-Alifonso,a Shirley Tremell,a Joanna C. Sadler,a Monica Berry*b and
M. Carmen Galan*a
Selective, bioorthogonal and fast labeling of glycoconjugates in
living cells is a major challenge for synthetic and cellular biology.
Here we report the use imidazolium tagged-mannosamine derivative
(ITag-Man) for the non-covalent, rapid and site-specific labeling of
sialic acid containing glycoproteins using commercialN-nitrilotriacetate
fluorescent reagents in a range of cell lines.
Cell surface carbohydrates mediate cell–cell communication,
bacterial or viral adhesion, neural development and cell proli-
feration, viral infection, masking of immunological epitopes,
fertilization, neural development and cell proliferation among
others.1 Surface carbohydrates can differ considerably in disease
and health, and thus unique glycan markers can be exploited for
early disease diagnosis and the development of vaccines and
therapeutics.2 Metabolic oligosaccharide engineering (MOE) is a
strategy used to highjack physiological pathways by introducing
unnatural monosaccharides bearing small chemical reporters to
monitor glycosylation changes.3 The labelled glycans can be
transformed by the cell biosynthetic machinery into activated
nucleotide sugars that are transported into the Golgi and then
transferred to glycoconjugates destined for secretion, delivery
to cellular compartments or presentation on the cell surface.
A number of metabolic glycan reporters based on the structures of
N-acetyl-mannosamine (ManNAc), N-acetyl-glucosamine (GlcNAc),
N-acetyl-galactosamine (GalNAc) or fucose (Fuc) have been suc-
cessfully used to disrupt glycan biosynthesis, chemically modify
cell surfaces, probe intracellular metabolic flux inside cells, and to
identify specific glycoprotein subtypes from the proteome.3,4
N-Azidoacetylmannosamine (ManNAz) is one of the most
common probes used to visualize sialic acid-containing carbo-
hydrates.ManNAz utilizes an azide functional group as the chemical
reporter that can be selectively derivatized, upon being metabolized,
using the Staudinger ligation,5 the Cu(I) catalyzed6 or the strain-
promoted7 azide–alkyne [3 + 2] cycloaddition. More recently, other
bioorthogonal metabolic chemical reporters that also rely on the
covalent modification of the functional group at C-2 of the manno-
samine moiety have been developed.8 Some of these strategies
include the use of alkenes that are selectively labeled by Diels Alder
reaction with inverse electron demand with a suitable fluoro-
phore,8,9 the use of isonitriles10 and cyclopropenes11 that can
react with tetrazine derivatives in a click type reaction, as well
as N-propargyloxycarbamates that are tagged by azide-bearing
molecules.12 Another elegant approach uses photoactivatable
diaziridine crosslinkers to covalently trap interactions among
glycoproteins.13 Despite recent advances and provided that
different glycan labelling probes have been shown to follow
different metabolic pathways,12 new labeling strategies that are
fast, mild, bioorthogonal are still needed for the discovery and full
identification of new glycan biomarkers in living cells. Further-
more, the labelling should be non-toxic to cells even at long
exposure times, and should minimise undesired phenotypical
changes that would compromise the interpretation of the results.
Herein we report a new ionic probe (ITag-mannosamine) that is
metabolically incorporated into cell-surface sialic acids and that is
selectively and efficiently detected by non-covalent labeling
with commercial fluorescent Ni2+:N-nitrilotriacetate (NTA-Atto).
Moreover, using affinity chromatography we were able to isolate
ITag-bearing glycoproteins directly from cell lysates.
Non-covalent interactions to form stable complexes between
a marker and a biomolecule of interest are often used in cell
biology,14 because the methods are less harsh than covalent
strategies and labeling occurs at a faster rate and at physio-
logical pH. Ionic liquids (ILs) have recently become very attrac-
tive tunable ionic supports for the immobilization of reagents.15
Our group recently reported the use of imidazolium-based IL
tags (ITags) as purification labels and mass spectroscopy (MS)
reporters in chemical and enzymatic oligosaccharide elongation
processes.16 Encouraged by our results, we anticipated that the
small cationic imidazolium moiety present in an ITag would be
ideally suited for MOE (Fig. 1).
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To that end, peracetylated ITag-mannosamine (Ac4ManN-ITag, 2)
was prepared from mannosamine hydrochloride, in two steps
and 45% overall yield, by reaction with 3-methyl-1-imidazol-3-
ium-propionic acid17 using EDC and Et3N in dimethylformamide
(DMF), followed by acetylation with Ac2O and pyridine (Scheme 1).
Deacetylation of 2 followed by treatment with commercial D-sialic
acid aldolase18 in the presence of pyruvate, yielded the corres-
ponding neuraminic acid derivative 3 (see ESI,† for details),
demonstrating that the ITag is tolerated by an aldolase.
Ni2+:NTA-Atto complexes are extensively used as site-specific
fluorescent labels for proteins containing oligohistidine-Tags.19
Moreover, imidazolium based ILs can form stable adducts with
cation chelating/polyanion bearing molecules.20 To further explore
the potential utility of the reagent in our system, NMR titrations
using model IL 3-methyl-1-imidazol-3-ium-propionate with NTA
analogueN-acetyl-Na,Na-bis(carboxymethyl)-L-lysine in the absence
of Ni2+ showed that the IL interacts with the model NTA label
in PBS buﬀer (pH 7.4) with an approximate binding constant of
22  9 mM1 (see ESI,† for details).21
A number of cell lines, including Jurkat T-lymphocytes,
breast cancer cell line MDA-MB-231 (MDA), colon cancer cell
line HT29-MTX-E12 (E12), cervical cancer cells HeLa and SV40-
immortalized human corneal epithelium (AS) cells were incu-
bated for 3 days5 in the presence of a range of concentrations of
2 (0.2–200 mM). Surface expression of Neu-5-N-ITag 4 was then
assessed by exposure with fluorescent NTA-Atto 550 (5  108 M)
for 1 h at 37 1C. Confocal fluorescence microscopy clearly showed
labeling of the cell membrane for the ITag-labeled cell lines in
comparison to controls22 (Fig. 2). Fluorescence quantification
revealed that expression of ITag on the cell surface varied with
cell line, which is to be expected since different cell lines will have
a differential expression of sialic acid (Fig. 3). No effect on cell
numbers and metabolic activity was detected after these expo-
sures (see ESI,† for further details). In addition, HeLa, MDA and
E12 cells that had been incubated with 2 (2 mM), were treated
with neuraminidase from Arthrobacter ureafaciens to remove cell
surface sialic acids prior to NTA-Atto exposure. Encouragingly,
cells that had been exposed to the sialidase, showed a decrease in
fluorescence when compared to controls (2 treated cells). These
results suggest that the sialidase is able to hydrolise ITag-bearing
sialic acids and that NTA-Atto binds to ITag-bearing sialic acids
on the cell surface.
To test whether the overall electronic charge of the cell
surface was altered by the expression of imidazolium-bearing
glycans, we measured the electrokinetic potential (zeta potential)23
of AS, HeLa, Jurkat and MDA cells after treatment with 2 at
0–20 mM concentrations. For AS and MDA cells, no significant
changes in zeta potential could be detected, while for Jurkat
and HeLa the largest negative values were measured at low
concentrations of 2 with charges being restored to control values
with exposure to increased concentrations of 2. These small
variations could be attributed to changes in glycan expression
prompted by the ITag-moieties (See Fig. S6 in ESI†).
To determine the eﬀect of ITag-probe 2 on cell surface
neuraminic acid expression, AS, HeLa, Jurkat, E12, and MDA
cells treated with equal concentrations of 2 were incubated with
sialic acid specific biotinylated lectins: Sambucus nigra agglutinin
(SNA), which binds to terminal a-2,6-linked sialic acids preferen-
tially, and Maackia Amurensis Lectin II (MAA), which prefers to
bind sialic acid in an a-2,3-linkage. Lectin binding was then
quantified using Neutravidin DyLight 649 (2 mg mL1) and results
Fig. 1 General strategy for the use of ITag-sugars as non-covalent probes
in MOE.
Scheme 1 Synthesis of Ac4ManN-ITag 2.
Fig. 2 Confocal images of E12 cells stained with nucleus staining NucBlues
and NTA-ATTO 550 (red). (A) untreated cells and (B) cells incubated with 2 at
2 mM for 72 h. For a clearer image, please refer to the electronic version of
this manuscript.
Fig. 3 Ni2+:NTA-ATTO labeling of the cell surface after incubation with
2 (2 mM shown) in complete cell growth. medium for 72 h. Fluorescence is
expressed as % of control (100%).
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compared to untreated controls where these moieties are
natively expressed.24 In addition to diﬀerential expression of
ITag on the cell surface, the linkage of sialic acids in response
to 2 depended on the cell line. Ratios of a-2,6-linked and a-2,3-
linked sialic acid expression varied between the diﬀerent cell
lines investigated and also depended on the dose of 2 to which
they have been exposed (Fig. 4 and Fig. S8 in ESI†). A consistent
and similar increase in a-2,3-sialic acid expression (over a-2,6-
linked) upon treatment with 2 was observed in all cell lines with
the exception of mucin-secreting E12 cells, in which the a-2,6-
linkage increased and the a-2,3-decreased. Moreover, AS and
HeLa cells presented increased a-2,6-sialic acid levels with
respect to untreated controls.25
Discrete glycocalyx alterations, such as relative changes in
the composition of sialic acids, have been linked to changes in
cell adhesion.26 Calcein AM was used to quantify the number of
live cells in MDA, Jurkat, E12 and HeLa cells, adhering to
fibronectin-coated plates. Alterations in cell surface sialic acid
expression observed on incubation with 2, were insuﬃcient to
aﬀect the number of adherent cells relative to untreated controls.
Interestingly, further evaluation of the ITag-treated cells showed
that after exposure to increased concentrations of 2 (200 mM),
adherent cells expressed significantly less surface ITag than cells
remaining in solution. (Fig. S9–S11 in ESI†) Effects on cell–cell
aggregation were also quantified by the adherence of MDA,
Jurkat, HeLa and E12 cells, that had been pretreated with 2 at
20 mM, tomonolayers of treated or untreated MDA, HeLa and E12
cells, or to naked wells, in different combinations. No significant
differences were observed for cell aggregation of any of the ITag-
treated cells to treated or untreated cell monolayers. However, the
adherence of treated cells to the naked culture plate was modified
in a cell dependent manner (See Fig. S12 in ESI,† for further
details). These alterations are concordant with modest variations
in sialic acid populations at the cell surface, highlighting the
importance of these glyco-epitopes in cell and tissue biology.
Encouraged by the simplicity of our protocol, we evaluated
the feasibility of using aﬃnity chromatography to isolate the
glycoproteins with the metabolically incorporated ITags directly
from the cell lysates. To that end, the lysate of ITag 2 (20 mM)
treated MDA cells were subjected to purification over a HitrapTM
Q HP aﬃnity column (which provides a chelate aﬃnity medium)
and proteins were eluted using an imidazolium gradient. Western
blots of purified lysates (lanes 3–5) displayed discrete bands of
similar molecular weights (around 50 kDa, Fig. 5 and Fig. S13 in
ESI†) and their specificity was tested by reaction with sialic acid
binding lectins. Excitingly, ITag-treated lysates showed an enrich-
ment of sialic acid containing glycoproteins as revealed by lectin
staining (lane 4 vs. control in lane 3, Fig. 5).27 In addition, ITag-
treated lysates exposed to mercaptoacetic acid coated fluorescent
quantum dots (QD–COOH)28 also tested positive on the blots
(lane 5), further suggesting that the band corresponds to a
glycoprotein bearing an ITag-labeled sialic acid.
In conclusion, we have developed a new class of imidazolium-
based glycan probes (ITag-Man) for non-covalent labeling of
glycoconjugates in live cells with commercial fluorescent NTA-
Atto 550. The labeling is mild, fast, bioorthogonal and compli-
mentary to current labeling methods. We demonstrated that
the ITags are well tolerated by a number of cell lines and do not
have a significant eﬀect on cell adhesion or the overall electro-
nic cell surface charges, however the ionic labels do have an
impact on the type of sialic acid that is expressed on the cell
surface (a-2,3- vs. a-2,6). In addition, a chelating aﬃnity column
was successfully used to enrich the sample with glycoproteins
specifically labeled with the new ITag-sialic acid moieties. The
methodology reported here, provides a unique and practical
way to label specific glycoproteins present in a variety of cells.
Given the bioorthogonality and mild nature of the tags, combined
with the simplicity of the protocol, we believe that the use of ITags
for labeling biomolecules will not be restricted to metabolic oligo-
saccharide engineering, but should be broadly applicable to other
biological systems.
We gratefully acknowledge financial support from EPSRC
grant number EP/J002542/1 and ERC-COG (ID 648239).
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